[Thromboembolic disease: prevention with low-molecular weight heparin in general surgery. Preliminary results].
Nine patients undergoing surgery lasting more than 45 minutes were included in the study. They received weekly anti-thromboembolic treatment with parnaparin (INN). Patients did not present thromboembolic complications following clinical and instrumental examination. Blood loss remained within the norm and no collateral effects were observed.
Servizio di Anestesia, Rianimazione, USL n. 6, Ospedale Civile, Fossombrone, Pesaro.
F
F
Pietrelli
T
T
Renzoni
C
C
Cicoli
D000368:Aged; D005260:Female; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D013514:Surgical Procedures, Operative / Q000009:adverse effects; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control*
D006495:Heparin, Low-Molecular-Weight; C080945:parnaparin
La malattia tromboembolica: prevenzione con eparina a basso peso molecolare in chirurgia generale. Risultati preliminari.